Todd Morgan

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Prokar Dasgupta

King’s College London

UNITED KINGDOM

View details

Cathryn Lapedis

University of Michigan

UNITED STATES

View details

Benjamin Pradere

Medical University of Vienna

AUSTRIA

View details

Daniel Barocas

Professor and Executive Vice Chair

Vanderbilt University Medical Center

UNITED STATES

View details

Kerri Beckmann

University of South Australia

AUSTRALIA

View details

Simpa Salami

University of Michigan

UNITED STATES

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Anders Bjartell

SWEDEN

View details

Nikhil Vasdev

Professor and Chair of Robotic Surgery and Urology

University of Hertfordshire

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Todd Morgan

Research Interests

Explore related searches

Contact this professor

Articles (29)

IP16-30 DO TISSUE-BASED BIOMARKERS IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA PERFORM BETTER WHEN DERIVED FROM A METASTATIC SITE COMPARED TO THE PRIMARY?

MP28-03 VALIDATION OF A 15-GENE PROGNOSTIC SIGNATURE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA

How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic Test

Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study

National Institutes of Health Funding Reform: Potential Implications for Urologic Researchers

HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice

The value of integrating urology and oncology real-world data for understanding prostate cancer management.

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials

IP04-10 ARE VETERANS WITH PROSTATE CANCER SCIENTIFICALLY UNDERSERVED? DESCRIBING ACCESS TO PROSTATE CANCER CLINICAL TRIALS IN THE VA

Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing

MRI-Visible and -Invisible Prostate Cancer

Financial Implications of Prostate MRI Without Contrast.

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer

Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer

Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG 3506 (STEEL).

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC).

Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma

The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.

Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer

Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Risk of progression following a negative biopsy in prostate cancer active surveillance

Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

MP17-11 REFINEMENT AND EXTERNAL VALIDATION OF A NOVEL MULTIPLEX URINE TEST FOR HIGH-GRADE PROSTATE CANCER

Collaborators (9)

Prokar Dasgupta

Cathryn Lapedis

Benjamin Pradere

Daniel Barocas

Kerri Beckmann

Simpa Salami

Robert Dess

Anders Bjartell

Nikhil Vasdev

Make your next move.